Hikal Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Hikal Share Price

183.997.85 (4.46%)

Closed
As On: 12 Jun, 2026, 03:52 PM IST
As On: 12 Jun, 2026, 03:57 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	180.07
High	185.20
Low	178.55
Prev Close	176.15
Volume	1,47,486
VWAP(₹)	181.60

Key Metrics

PE Ratio(x)	-46.49
EPS - TTM(₹)	-3.96
MCap(₹ Cr.)	2,268.61
MCap Rank	78
PB Ratio(x)	1.83
Div Yield(%)	0.33
Face Value(₹)	2.00
52W High(₹)	386.25
52W Low(₹)	146.25
MCap/Sales	1.06
Beta(1 Month)	0.42
BV/Share(₹)	97.23

Hikal Ltd share price insights

PAT: Entering the Green
Company has posted a profit of Rs 14.4 cr in Mar 31, 2026 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 3.63% of its operating revenues towards interest expenses and 15.78% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Hikal Ltd Share Price Update
Hikal Ltd. share price moved up by 4.46% from its previous close of Rs 176.15. Hikal Ltd. stock last traded price is 183.99
Share Price Value
Today/Current/Last 183.99184.00
Previous Day 176.15174.95

Found Insights useful?

Hikal Ltd Share Price Returns

1 Day	4.46%
1 Month	-7.39%
3 Months	2.07%
1 Year	-51.47%
3 Years	-41.63%
5 Years	-60.8%

Hikal Share Recommendations

Mean recosCurrent

STRONG BUY

1 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	1	1	1	1
Buy	-	-	-	-
Hold	-	-	-	1
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	1	1	1	2

Recent Recos

Target₹324
OrganizationHDFC Securities
BUY

Target₹450
OrganizationPrabhudas Lilladher
BUY

Target₹340
OrganizationICICI Direct
BUY

View all Stock Recommendations

News & Analysis

View all Hikal Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	526.00	497.10	320.40	381.40	552.90
Total Income Growth (%)	5.81	55.15	-15.99	-31.02	22.51
Total Expenses	503.10	490.80	352.50	394.70	466.70
Total Expenses Growth (%)	2.51	39.23	-10.69	-15.43	14.16
EBIT	22.90	6.30	-32.10	-13.30	86.20
EBIT Growth (%)	263.49	-	-	-115.43	102.82
Profit after Tax (PAT)	14.40	-5.90	-34.90	-22.40	50.20
PAT Growth (%)	-	-	-	-144.62	191.86
EBIT Margin (%)	4.35	1.27	-10.02	-3.49	15.59
Net Profit Margin (%)	2.74	-1.19	-10.89	-5.87	9.08
Basic EPS (₹)	1.17	-0.48	-2.83	-1.82	4.07

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	526.00	497.10	320.40	381.40	552.90
Total Income Growth (%)	5.81	55.15	-15.99	-31.02	22.51
Total Expenses	502.90	490.80	352.30	395.00	466.60
Total Expenses Growth (%)	2.47	39.31	-10.81	-15.35	14.17
EBIT	23.10	6.30	-31.90	-13.60	86.30
EBIT Growth (%)	266.67	-	-	-115.76	102.58
Profit after Tax (PAT)	14.60	-5.90	-34.70	-22.70	50.30
PAT Growth (%)	-	-	-	-145.13	190.75
EBIT Margin (%)	4.39	1.27	-9.96	-3.57	15.61
Net Profit Margin (%)	2.78	-1.19	-10.83	-5.95	9.10
Basic EPS (₹)	1.18	-0.48	-2.81	-1.84	4.08

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,724.90	1,864.80	1,787.05	2,028.44	1,947.61
Total Revenue Growth (%)	-7.50	4.35	-11.90	4.15	12.88
Total Expenses	1,718.10	1,741.00	1,691.55	1,923.08	1,729.05
Total Expenses Growth (%)	-1.32	2.92	-12.04	11.22	13.83
Profit after Tax (PAT)	-48.80	90.80	69.60	78.38	160.50
PAT Growth (%)	-153.74	30.46	-11.20	-51.16	20.55
Operating Profit Margin (%)	4.02	10.70	8.51	7.58	12.85
Net Profit Margin (%)	-2.84	4.88	3.90	3.87	8.26
Basic EPS (₹)	-3.96	7.36	5.64	6.36	13.02

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,724.90	1,864.80	1,787.05	2,028.44	1,947.61
Total Revenue Growth (%)	-7.50	4.35	-11.90	4.15	12.88
Total Expenses	1,718.00	1,740.90	1,691.63	1,923.08	1,729.04
Total Expenses Growth (%)	-1.32	2.91	-12.04	11.22	13.83
Profit after Tax (PAT)	-48.70	90.90	69.51	78.38	160.51
PAT Growth (%)	-153.58	30.77	-11.31	-51.17	20.55
Operating Profit Margin (%)	4.02	10.70	8.50	7.58	12.85
Net Profit Margin (%)	-2.84	4.88	3.89	3.87	8.26
Basic EPS (₹)	-3.95	7.37	5.64	6.36	13.02

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Entering the Green
Company has posted a profit of Rs 14.4 cr in Mar 31, 2026 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 3.63% of its operating revenues towards interest expenses and 15.78% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	2,365.40	2,528.90	2,487.15	2,385.48	2,213.11
Total Assets Growth (%)	-6.47	1.68	4.26	7.79	15.67
Total Liabilities	1,166.60	1,266.60	1,299.49	1,252.01	1,145.13
Total Liabilities Growth (%)	-7.90	-2.53	3.79	9.33	16.87
Total Equity	1,198.80	1,262.30	1,187.66	1,133.47	1,067.98
Total Equity Growth (%)	-5.03	6.28	4.78	6.13	14.42
Current Ratio (x)	1.30	1.26	1.28	1.42	1.25
Total Debt to Equity (x)	0.57	0.60	0.69	0.66	0.63
Contingent Liabilities	0.00	325.80	322.13	225.15	148.28

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	2,365.40	2,529.10	2,487.07	2,385.48	2,213.12
Total Assets Growth (%)	-6.47	1.69	4.26	7.79	15.67
Total Liabilities	1,166.40	1,266.90	1,299.48	1,251.99	1,145.11
Total Liabilities Growth (%)	-7.93	-2.51	3.79	9.33	16.87
Total Equity	1,199.00	1,262.20	1,187.59	1,133.49	1,068.01
Total Equity Growth (%)	-5.01	6.28	4.77	6.13	14.42
Current Ratio (x)	1.30	1.26	1.28	1.42	1.25
Total Debt to Equity (x)	0.57	0.60	0.69	0.66	0.63
Contingent Liabilities	0.00	325.80	322.13	225.15	148.28

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	302.00	280.40	186.72	315.31	293.73
Net Cash used in Investing Activities	-145.30	-136.50	-173.75	-292.34	-284.37
Net Cash flow from Financing Activities	-160.10	-143.60	-27.00	-7.68	-5.56
Net Cash Flow	-3.40	0.30	-14.03	15.29	3.80
Closing Cash & Cash Equivalent	9.60	13.00	12.70	26.73	11.44
Closing Cash & Cash Equivalent Growth (%)	-26.15	2.34	-52.48	133.63	49.81
Total Debt/ CFO (x)	2.26	2.72	4.36	2.37	2.30

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	302.10	280.40	186.62	315.29	293.73
Net Cash used in Investing Activities	-145.30	-136.50	-173.75	-292.34	-284.37
Net Cash flow from Financing Activities	-160.10	-143.60	-27.00	-7.68	-5.56
Net Cash Flow	-3.30	0.30	-14.12	15.27	3.80
Closing Cash & Cash Equivalent	9.60	12.90	12.60	26.71	11.44
Closing Cash & Cash Equivalent Growth (%)	-25.58	2.42	-52.85	133.49	49.81
Total Debt/ CFO (x)	2.25	2.72	4.37	2.37	2.30

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 145.3 cr for investing activities which is an YoY increase of 6.45%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-4.07	7.19	5.86	6.91	15.02
Return on Capital Employed (%)	4.08	11.44	8.77	8.90	17.29
Return on Assets (%)	-2.06	3.59	2.79	3.28	7.25
Interest Coverage Ratio (x)	3.75	4.43	4.78	5.46	11.07
Asset Turnover Ratio (x)	0.70	0.74	0.73	0.88	0.94
Price to Earnings (x)	-37.31	54.64	46.95	44.44	30.96
Price to Book (x)	1.51	3.91	2.75	3.07	4.65
EV/EBITDA (x)	10.67	17.05	15.06	15.87	16.17
EBITDA Margin (%)	13.58	17.92	15.10	12.97	17.78

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	-4.06	7.20	5.85	6.91	15.02
Return on Capital Employed (%)	4.09	11.44	8.77	8.90	17.29
Return on Assets (%)	-2.05	3.59	2.79	3.28	7.25
Interest Coverage Ratio (x)	3.75	4.43	4.78	5.46	11.07
Asset Turnover Ratio (x)	0.70	0.74	0.73	0.88	0.94
Price to Earnings (x)	-37.31	54.64	47.17	44.44	30.96
Price to Book (x)	1.51	3.91	2.75	3.07	4.65
EV/EBITDA (x)	10.67	17.05	15.07	15.87	16.17
EBITDA Margin (%)	13.59	17.93	15.09	12.97	17.78

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
42%
Positive Movement
since 1st Jan 2005
on basis
57%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Hikal Ltd	-46.49	1.89	-4.07	4.08	-2.06	-5.21	4.02	-2.84	-3.96	1.30	0.57	2.26
Orchid Pharma	228.53	3.61	1.59	2.50	1.07	7.22	5.03	2.61	4.05	2.45	0.28	3.53
Gujarat Themis	90.40	14.66	16.22	15.32	9.27	2.74	39.22	28.15	4.28	1.12	0.56	3.28
IOL Chemicals	28.63	2.19	7.65	11.07	5.32	1.42	9.06	5.93	4.69	1.78	0.07	0.62
Gufic BioSci	57.98	5.60	9.65	14.93	4.78	10.83	13.04	6.80	6.40	1.55	0.58	8.57
Add More

Annual Ratios (%)

Choose from Peers

RPG Life Sci
Panacea Biotec
Unichem Labs
Solara Active Pharma
Morepen Labs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 8,48,92,764 68.85 % 0.00
Pledge 0 0.00 % 0.00
FII 17,65,980 1.44 % -0.86
DII 88,78,028 7.20 % 0.15
MF 73,01,796 5.92 % 0.20
Others 2,77,63,978 22.51 % 0.70
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 68.85 68.85 68.85 68.85
Pledge 0.00 0.00 0.00 0.00
FII 1.44 2.30 4.22 5.35
DII 7.20 7.05 5.15 4.03
Mutual Funds 5.92 5.71 4.09 2.97
Others 22.51 21.80 21.78 21.77

Mutual Funds Ownership

MF Ownership as on 30 April 2026

ICICI Pru Pharma Healthcare and Diagnostics (P.H.D) Direct-G
Equity: Sectoral-Pharma
4
- 75.70
  Amount Invested (in Cr.)
- 1.13513762%
  % of AUM
- 0.00
  % Change (MoM basis)
Tata Small Cap Direct-G
Equity: Small Cap
2
- 62.45
  Amount Invested (in Cr.)
- 0.55%
  % of AUM
- 0.00
  % Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.02
  Amount Invested (in Cr.)
- 0.04994109%
  % of AUM
- -3.76
  % Change (MoM basis)

View all Mutual Fund Schemes

Hikal Ltd Top Searches

Corporate Actions

Recent
General Meeting
-
Jun 04, 2026
Final
20%
May 27, 2026
Board Meeting
Audited Results & Final Dividend
May 20, 2026

Announced on	Meeting on
May 20, 2026	May 27, 2026
Audited Results & Final Dividend
Feb 04, 2026	Feb 11, 2026
Quarterly Results & Interim Dividend
Nov 06, 2025	Nov 13, 2025
Quarterly Results
Nov 06, 2025	Nov 06, 2025
Quarterly Results
Jul 31, 2025	Aug 07, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
Feb 11, 2026 Feb 17, 2026 10%
May 14, 2025 Sep 02, 2025 40%
Feb 04, 2025 Feb 07, 2025 30%
May 09, 2024 Sep 04, 2024 30%
May 27, 2026 - 20%

Announced on	Ex-Date
May 09, 2018	Jun 22, 2018
Bonus Ratio: 1 share(s) for every 2 shares held
Jul 14, 2003	Sep 29, 2003
Bonus Ratio: 1 share(s) for every 2 shares held
May 13, 2000	Aug 23, 2000
Bonus Ratio: 1 share(s) for every 1 shares held

Splits
Announced on Ex-Date
Dec 17, 2014 Feb 27, 2015
Split: Old FV10.0| New FV:2.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Jun 04, 2026 Jul 06, 2026
-
Aug 07, 2025 Sep 23, 2025
-
Aug 22, 2024 Sep 17, 2024
Rs.0.6000 per share(30%)Final Dividend & A.G.M.
Feb 19, 2024 Mar 22, 2024
-
Nov 24, 2023 Dec 26, 2023
-

About Hikal

Hikal Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 2,268.61 Crore) operating in Pharmaceuticals sector.

Hikal Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 526.00 Crore, up 5.81 % from last quarter Total Income of Rs 497.10 Crore and down 4.87 % from last year same quarter Total Income of Rs 552.90 Crore. Company has reported net profit after tax of Rs 14.40 Crore in latest quarter.

The company’s top management includes Mr.Jai Hiremath, Mr.Sameer Hiremath, Mr.Sarangan Suresh, Mr.Amit Kalyani, Ms.Sugandha Hiremath, Mr.Berjis Desai, Mr.Ramachandra Kaundinya, Mr.Ranjana S Salgaocar, Mr.Ravi Kapoor, Mrs.Shivani Bhasin Sachdeva, Mr.Shrikrishna Adivarekar, Mr.Kuldeep Jain, Mr.Rajasekhar Reddy. Company has S R B C & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 12.33 Crore shares outstanding.

Hikal Ltd Share Price Today is Rs. 183.99. On previous day, the Hikal Ltd Share Price (NSE) closed at Rs. 176.15, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 68.85% of the stake in Hikal Ltd shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Hikal Ltd stocks was 1.44% as compared to 2.31% in Dec 2025 with decrease of 0.87%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 7.2% as compared to 7.05% in Dec 2025 with increase of 0.15%. Out of the total DII holdings in Hikal Ltd shares 5.92% was held by mutual funds. The rest including public held is 22.51%. Hikal Ltd stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Hikal Ltd Dividend: Ever since 1988, Hikal Ltd dividends has been paid out around 53 times. As on 12 Jun, 2026, 03:52 PM IST, The overall dividend yield for Hikal Ltd stands at 0.34%. The last dividend paid was on February 17, 2026 (Rs. 0.2). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -3.96.

Hikal Ltd Bonus: The most recent bonus issue had been in year June 22, 2018 around 7 years ago at 2 : 1 ratio. The first bonus issue was announced in May 2000.

Stock Forecast:
After showing 528.4 Cr. of sales and 5.53% of quarterly net profit, there have been multiple ups and downs in the Hikal Ltd stock prices in the past few weeks. For example, Hikal Ltd stock price on 5th of June 2026 was around Rs. 189.62. Hikal Ltd share price now stands at an average of Rs. 183.99. Judging by last week's performance, stock is in down trend.

Hikal Ltd has a median target price of Rs. 292.5 in 12 months by 2 analysts. They have provided a high estimate of Rs. 300.0 and low estimate of Rs. 285.0 for Hikal Ltd share.

Historical Prices and Performance:
Hikal Ltd, incorporated in 1988 is a Small Cap company (with a market cap of Rs. 2268.61) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Hikal Ltd stock was -4.07%, 7.19%, 5.86%, 6.91% and 15.02% respectively.
The Hikal Ltd share gave a 3 year return of -41.63% as compared to Nifty 50 which gave a return of 26.99%.
Hikal Ltd announced 10.0% final dividend on February 17, 2026.

Key Metrics:
PE Ratio of Hikal Ltd is -44.51
Prices/Sales Ratio of Hikal Ltd is 1.06
Price/Book Ratio of Hikal Ltd is 1.81

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Hikal Ltd, major competitors and peers include Orchid Pharma, Gujarat Themis, IOL Chemicals and Gufic BioSci. As of Dec 2025, the dividend yield of Hikal Ltd stands at 0.34% while Orchid Pharma, Gujarat Themis, IOL Chemicals and Gufic BioSci stand at 0.0%, 0.17%, 0.74% and 0.03% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -44.51 and 1.81 respectively.

Leadership of Hikal Ltd :
Rajasekhar Reddy is Co. Secretary & Compl. Officer
Kuldeep Jain is Chief Financial Officer
Manoj Mehrotra is President
Vimal Kulshrestha is President
Ratish Jha is President - HR
Anish Swadi is Senior President
Jai Hiremath is Executive Chairman
Sameer Hiremath is Vice Chairman & Mng.Director
Sarangan Suresh is Whole Time Director
Sugandha Hiremath is Non Executive Director
Amit Kalyani is Non Executive Director
Shivani Bhasin Sachdeva is Ind. Non-Executive Director
Shrikrishna Adivarekar is Ind. Non-Executive Director
Ramachandra Kaundinya is Ind. Non-Executive Director
Berjis Desai is Ind. Non-Executive Director
Ravi Kapoor is Ind. Non-Executive Director
Ranjana S Salgaocar is Ind. Non-Executive Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, Nifty Smallcap 500

Address

717/718, Maker Chambers V,Nariman Point,Mumbai, Maharashtra - 400021

Contact

http://www.hikal.com

Executive Leadership

JH

Jai Hiremath

Executive Chairman

SH

Sameer Hiremath

Vice Chairman & Mng.Director

SS

Sarangan Suresh

Whole Time Director

AK

Amit Kalyani

Non Executive Director

Show More

Auditors

S R B C & Co. LLP

B S R & Co. LLP

FAQs about Hikal share

1. What is Hikal Ltd share price and what are the returns for Hikal Ltd share?
As on 12 Jun, 2026, 03:52 PM IST Hikal Ltd share price is up by 4.46% basis the previous closing price of Rs 178.31. Hikal Ltd share price is Rs 183.99. Return Performance of Hikal Ltd Shares:
- 1 Week: Hikal Ltd share price moved down by 2.97%
2. What's the market capitalization of Hikal Ltd?
Hikal Ltd share has a market capitalization of Rs 2,268.61 Cr. Within Pharmaceuticals sector, it's market cap rank is 78.
3. What has been highest price of Hikal Ltd share in last 52 weeks?
52 Week high of Hikal Ltd share is Rs 386.25 while 52 week low is Rs 146.25
4. What are the returns for Hikal Ltd share?
Return Performance of Hikal Ltd Shares:
- 1 Week: Hikal Ltd share price moved down by 2.97%
5. What is the PE & PB ratio of Hikal Ltd?
The PE ratio of Hikal Ltd stands at -44.51, while the PB ratio is 1.81.

Top Gainers

As on 04:06 PM | 12 Jun 2026

1,028.70

714.90 (227.82%)

Netweb Technologies

4,587.40

2780.60 (153.90%)

Syrma SGS Technology

1,266.70

737.70 (139.45%)

14.90

8.12 (119.76%)

4,942.50

2633.90 (114.09%)

Top Losers

As on 03:58 PM | 12 Jun 2026

Tata Investment

665.90

-6218.10 (-90.33%)

339.50

-2678.10 (-88.75%)

757.55

-3315.15 (-81.40%)

403.30

-1723.50 (-81.04%)

Authum Investment

530.15

-1967.65 (-78.78%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.